Specialty Pharmacy

New antiretroviral combination will be accessible to patients with HIV/AIDS in countries with limited resources.

Adolescent and young adult cancer survivors have a higher rate of heart disease, infertility, and cancer recurrence.

The Cx26 protein may be involved with promoting aggressive breast cancer.

An experimental antiviral drug shows promise fighting multiple infectious diseases.

Matt Gillin, Chief Executive Officer, Relay Network, speaks about takeaways specialty pharmacies can learn from other businesses in terms of customer communications, adoption, and behavior change.

Top news of the day from across the health care landscape.

Amazon's acquisition of Whole Foods could lead to pharmacies closing their doors.

Federal judge finds that sofosbuvir (Sovaldi) and ledipasvir/sofosbuvir (Harvoni) do not infringe on Merck patents.

If passed, a bill that addresses the prevention and treatment of chronic diseases may ensure better care for patients.

Researchers discover underlying reason why patients with Huntington's disease have a significantly lower risk of cancer.

Top news of the day from across the health care landscape.

Patients who achieved hepatitis C virus eradication experienced a reduction in hepatic steatosis and fibrosis.

Combining oncolytic viruses and immunotherapies may fight cancer more effectively.

Treatment with durvalumab (Imfinzi) reduces the risk of disease progression among patients with non-small cell lung cancer.

Enzalutamide (Xtandi) demonstrates a significant reduction in metastasis or death from castration-resistant prostate cancer

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.

PRDM14 is involved with embryonic development and may lead to germ cell tumors.

Top news of the day from across the health care landscape.

Many key specialty pharmacy issues discussed at the Payer/Managed Care Strategies for Specialty Medications Annual Symposium.

Health care professionals should provide resources that help patients with HIV practice self-care.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Crystalized dolutegravir may be able to reach viral reservoirs and cure HIV.

Lorlatinib was designed to bypass non-small cell lung cancer mutations that promote drug resistance

A gene that plays a crucial role in blood cell maturation can mutate and cause cancer to develop.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Rituximab (Rituxan) sparked remission among patients with pemphigus vulgaris.

A popular multiple sclerosis drug may increase the risk of a potentially-fatal brain infection.